静脉对乙酰氨基酚减少结直肠手术阿片类药物用量并促进康复:DOCIVA随机对照研究
DOCIVA研究为前瞻性多中心随机双盲安慰剂对照试验,纳入105例结直肠手术患者,评估静脉对乙酰氨基酚联合阿片PCA的效应。结果显示研究组术后24h和48h阿片消耗量显著低于对照组,疼痛评分更低,胃肠功能恢复、饮食医嘱时间及住院时间更短,术后肠梗阻发生率降低。
要点
- 静脉对乙酰氨基酚可显著减少结直肠术后24h和48h阿片类药物消耗量。
- 研究组疼痛评分在3、8、24、48h各时间点均低于对照组。
- 研究组胃肠功能恢复更快、住院时间更短、术后肠梗阻发生率更低。
核心结论
- 静脉对乙酰氨基酚有助于减少结直肠手术患者的阿片类药物消耗。
- 接受静脉对乙酰氨基酚的患者住院时间缩短、疼痛控制更好、肠功能恢复更快、术后肠梗阻发生率更低。
研究设计与样本
- 前瞻性、多中心、随机、双盲、安慰剂对照研究。
- 共纳入105例患者,排除后97例纳入分析(对照组n=50,研究组n=47)。
- 患者随机接受静脉对乙酰氨基酚或安慰剂,联合阿片类药物PCA。
主要发现
- 研究组24h阿片消耗量为21.5±1.8 mg吗啡当量(ME),对照组为36.4±4.1 mg ME(p=0.002)。
- 研究组48h阿片消耗量为35.0±3.3 mg ME,对照组为59.7±6.7 mg ME(p=0.002)。
- 研究组疼痛视觉模拟评分在3、8、24、48h均低于对照组(p=0.02、0.006、<0.01、0.02)。
- 研究组胃肠功能恢复时间、饮食医嘱时间及住院时间均低于对照组(p≤0.01、<0.01、0.002)。
- 研究组术后肠梗阻发生率为2.1%,对照组为22%(p=0.004)。
临床怎么用
- 结直肠手术围术期可考虑加用静脉对乙酰氨基酚作为多模式镇痛组成部分,以减少阿片用量及相关不良反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We hypothesized that administration of IV acetaminophen alone would reduce the opioid consumption in post-operative colorectal surgery and reduce the side effects of narcotics. METHODS: Patients were randomized to receive either IV acetaminophen or placebo in addition to opioid PCA. Primary endpoints evaluated were opioid consumption and pain visual analogue scale score (PVASS) during first 48 h post-operatively. Secondary endpoints evaluated were time of return of GI function (ROGIF), time to diet ordered (TTDO), length of hospital stay (LOHS), and occurrence of ileus. RESULTS: 105 patients were enrolled and 97 remained in the study after exclusion (control group n = 50; study group n = 47). Mean ± SEs of opioid consumption in the study group was 21.5 ± 1.8 mg of morphine equivalent (ME) and 35.0 ± 3.3 mg ME at 24 and 48 h, respectively, versus 36.4 ± 4.1 mg ME and 59.7 ± 6.7 mg ME in the control group (p = 0.002 and 0.002). PVASS levels were lower in the study group at all intervals at 3, 8, 24, and 48 h (p = 0.02, 0.006, < 0.01, and 0.02). ROGIF, TTDO, and LOHS were also found to be lower in the study group (p ≤ 0.01, < 0.01, and 0.002). The rate of ileus was reduced by using IV acetaminophen (22% vs 2.1%; p = 0.004). CONCLUSIONS: IV acetaminophen helps to reduce opioid consumption for patients undergoing colorectal surgery. Additionally, there appears to be a shortened length of hospital stay, better pain control, reduced time to return of bowel function, and lower rate of post-operative ileus in patients receiving IV acetaminophen.
引用
- Aryaie AH, Lalezari S, Sergent WK, et al. Decreased opioid consumption and enhance recovery with the addition of IV Acetaminophen in colorectal patients: a prospective, multi-institutional, randomized, double-blinded, placebo-controlled study (DOCIVA study). Surg Endosc. 2018. PMID: 29352454. doi:10.1007/s00464-018-6062-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。